Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |